Pioneering RNA Cell Therapy for
autoimmune diseases and cancer
Pioneering RNA Cell Therapy for autoimmune diseases and cancer
Our Commitment to our Patients
We are committed to developing potent yet safer cell therapies for patients with autoimmune diseases and cancer.
Our therapeutic candidates
We are conducting clinical trials in patients with myasthenia gravis and multiple myeloma.
Our team
We are an integrated team of physicians and scientists working to develop the safest, most effective RNA cell therapies for our patients.
Stay up to date on Cartesian
Cartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis
⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January 31, 2023 – Cartesian Therapeutics, a fully integrated, clinical-stage biotechnology company pioneering RNA…